Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nailya Bulatova

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Substance Use & Misuse|February 5, 2020
Patterns of Substance Use among Patients in Addiction Rehabilitation in JordanHaya Yasin, Nailya Bulatova, Mayyada Wazaify
Substance Use & Misuse|August 5, 2021
Pharmaceutical Care in the Treatment of Substance Use Disorders in Jordan: A Randomized Controlled TrialHaya Yasin, Nailya Bulatova, Mayyada Wazaify
Biomedical Reports|October 30, 2023
Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancerMalek Zihlif, Tareq Hameduh, Nailya Bulatova, et al.
Pediatric Nephrology (Berlin, Germany)|June 13, 2008
Recurrent ecchymoses after acute tacrolimus intoxicationKamal F Akl, Nailya Bulatova, Al-Motassem Yousef
Pharmaceutical Biology|February 26, 2016
The use of medicinal herbs in gynecological and pregnancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacologyAmal Akour, Violet Kasabri, Fatma U Afifi, et al.
Current Drug Safety|January 19, 2011
Adverse effects of tacrolimus in renal transplant patients from living donorsNailya Bulatova, Al-Motassem Yousef, Ghada Al-Khayyat, et al.
Diabetes & Metabolic Syndrome|May 22, 2018
Increased malondialdehyde vs. reduced sirtuin 1 in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetesSamar Abu Rkhaya, Nailya Bulatova, Violet Kasabri, et al.
Therapeutic Advances in Endocrinology and Metabolism|October 18, 2018
Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetesRawan Mohammad Al Saudi, Violet Kasabri, Randa Naffa, et al.
Hormone Molecular Biology and Clinical Investigation|January 23, 2019
Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetesRawan AbuZayed, Nailya Bulatova, Violet Kasabri, et al.
Pharmacy Practice|March 25, 2016
Associations between patient factors and medication adherence: A Jordanian experienceIman A Basheti, Sami Saqf El Hait, Eyad A Qunaibi, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Substance Use & Misuse|February 5, 2020
Patterns of Substance Use among Patients in Addiction Rehabilitation in JordanHaya Yasin, Nailya Bulatova, Mayyada Wazaify
Substance Use & Misuse|August 5, 2021
Pharmaceutical Care in the Treatment of Substance Use Disorders in Jordan: A Randomized Controlled TrialHaya Yasin, Nailya Bulatova, Mayyada Wazaify
Biomedical Reports|October 30, 2023
Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancerMalek Zihlif, Tareq Hameduh, Nailya Bulatova, et al.
Pediatric Nephrology (Berlin, Germany)|June 13, 2008
Recurrent ecchymoses after acute tacrolimus intoxicationKamal F Akl, Nailya Bulatova, Al-Motassem Yousef
Pharmaceutical Biology|February 26, 2016
The use of medicinal herbs in gynecological and pregnancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacologyAmal Akour, Violet Kasabri, Fatma U Afifi, et al.
Current Drug Safety|January 19, 2011
Adverse effects of tacrolimus in renal transplant patients from living donorsNailya Bulatova, Al-Motassem Yousef, Ghada Al-Khayyat, et al.
Diabetes & Metabolic Syndrome|May 22, 2018
Increased malondialdehyde vs. reduced sirtuin 1 in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetesSamar Abu Rkhaya, Nailya Bulatova, Violet Kasabri, et al.
Therapeutic Advances in Endocrinology and Metabolism|October 18, 2018
Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetesRawan Mohammad Al Saudi, Violet Kasabri, Randa Naffa, et al.
Hormone Molecular Biology and Clinical Investigation|January 23, 2019
Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetesRawan AbuZayed, Nailya Bulatova, Violet Kasabri, et al.
Pharmacy Practice|March 25, 2016
Associations between patient factors and medication adherence: A Jordanian experienceIman A Basheti, Sami Saqf El Hait, Eyad A Qunaibi, et al.
Pageof 3